We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

31 Jul 2020 20:51

Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine does to Europe -companies

July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.The doses would be manufactured...

Read more
31 Jul 2020 17:19

EU wraps up Sanofi talks aimed at securing coronavirus vaccine

BRUSSELS, July 31 (Reuters) - The European Union's executive on Friday wrapped up talks with French drugmaker Sanofi aimed at securing its COVID-19 vaccine for the 27-country EU bloc."The envisaged contract with Sanofi would provide for an option...

Read more
31 Jul 2020 12:55

TOP NEWS: US Promises USD2 Billion For Sanofi And Glaxo Virus Vaccine

TOP NEWS: US Promises USD2 Billion For Sanofi And Glaxo Virus Vaccine

Read more
31 Jul 2020 12:35

Washington to support GSK and Sanofi Covid-19 vaccine with $2.1bn

(Sharecast News) - GlaxoSmithKline and Sanofi have inked an agreement with the US government to speed up development and manufacturing of their Covid-19 vaccine candidate at scale.

Read more
31 Jul 2020 09:47

UK BROKER RATINGS SUMMARY: Goldman Likes John Wood; Peel Cuts YouGov

UK BROKER RATINGS SUMMARY: Goldman Likes John Wood; Peel Cuts YouGov

Read more
31 Jul 2020 05:41

TOP NEWS: Pentagon Awards Glaxo USD342 Million Contract For Vaccines

TOP NEWS: Pentagon Awards Glaxo USD342 Million Contract For Vaccines

Read more
30 Jul 2020 14:15

UPDATE 1-AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries

(Adds details on U.S. contract, background on product liability, U.S. law)By Ludwig Burger and Pushkala AripakaJuly 30 (Reuters) - AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful...

Read more
29 Jul 2020 16:56

LONDON MARKET CLOSE: Stocks Mixed As Market Awaits Dovish Fed Decision

LONDON MARKET CLOSE: Stocks Mixed As Market Awaits Dovish Fed Decision

Read more
29 Jul 2020 12:35

TOP NEWS: GSK Holds Forecast But Virus Hurts Second-Quarter Revenue

TOP NEWS: GSK Holds Forecast But Virus Hurts Second-Quarter Revenue

Read more
29 Jul 2020 12:35

UPDATE 2-GSK profit misses as vaccine sales disappoint, stockpiling eases

* Vaccine sales fall short of consensus* Reveals it is making adjuvant with no govt. funding* Shares down 2% (Writes through, adds CEO comments from media call, shares)By Pushkala Aripaka and Ludwig BurgerJuly 29 (Reuters) - Britain's GSK on Wednesd...

Read more
29 Jul 2020 12:35

UPDATE 1-GSK profit misses as vaccine sales disappoint, stockpiling eases

(Adds details on quarterly earnings)July 29 (Reuters) - Britain's GSK fell short of quarterly expectations for profit on Wednesday, as sales of its existing vaccines fell and stockpiling of pain and lung medication tapered as countries eased coron...

Read more
29 Jul 2020 12:30

GlaxoSmithKline stands by full-year EPS guidance but with a caveat

(Sharecast News) - GlaxoSmithKline saw its top line shrink over the second quarter, somewhat ironically as the Covid-19 pandemic disrupted its vaccines unit.

Read more
29 Jul 2020 12:30

GlaxoSmithKline stands by full-year EPS guidance but with a caveat

(Sharecast News) - GlaxoSmithKline saw its top line shrink over the second quarter, somewhat ironically as the Covid-19 pandemic disrupted its vaccines unit.

Read more
29 Jul 2020 12:12

GSK profit misses as Shingrix disappoints, stockpiling eases

July 29 (Reuters) - Britain's GSK fell short of quarterly expectations for profit on Wednesday, as sales of the drugmaker's blockbuster shingles vaccine fell and stockpiling of pain and lung medication tapered as countries eased lockdowns.Turnover...

Read more
29 Jul 2020 11:33

UK TOP NEWS SUMMARY: UK Signs Vaccine Supply Deal With Sanofi And GSK

UK TOP NEWS SUMMARY: UK Signs Vaccine Supply Deal With Sanofi And GSK

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.